Clinical Use of Carotid Intima-Media Thickness

Review of the Literature

R. Todd Hurst, Daniel W C Ng, Chris Kendall, Bijoy Khandheria

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Carotid intima-media thickness (CIMT) is a simple and inexpensive tool to assess the cumulative effect of atherosclerotic risk factors and is an independent predictor of future cardiovascular risk. CIMT is commonly used as a surrogate end point in research trials as a marker of atherosclerosis. However, new software programs have made CIMT a clinically practical examination for risk evaluation. CIMT correlates with cardiac risk factors and is an independent predictor of future myocardial infarction and stroke risk. Tests for subclinical atherosclerosis, such as CIMT, will help clinicians to more effectively identify the vulnerable patient who would benefit from aggressive prevention intervention.

Original languageEnglish (US)
Pages (from-to)907-914
Number of pages8
JournalJournal of the American Society of Echocardiography
Volume20
Issue number7
DOIs
StatePublished - Jul 2007

Fingerprint

Carotid Intima-Media Thickness
Atherosclerosis
Software
Biomarkers
Stroke
Myocardial Infarction
Research

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Clinical Use of Carotid Intima-Media Thickness : Review of the Literature. / Hurst, R. Todd; Ng, Daniel W C; Kendall, Chris; Khandheria, Bijoy.

In: Journal of the American Society of Echocardiography, Vol. 20, No. 7, 07.2007, p. 907-914.

Research output: Contribution to journalArticle

Hurst, R. Todd ; Ng, Daniel W C ; Kendall, Chris ; Khandheria, Bijoy. / Clinical Use of Carotid Intima-Media Thickness : Review of the Literature. In: Journal of the American Society of Echocardiography. 2007 ; Vol. 20, No. 7. pp. 907-914.
@article{dd21e29a7544469ba4d5dae5119a2212,
title = "Clinical Use of Carotid Intima-Media Thickness: Review of the Literature",
abstract = "Carotid intima-media thickness (CIMT) is a simple and inexpensive tool to assess the cumulative effect of atherosclerotic risk factors and is an independent predictor of future cardiovascular risk. CIMT is commonly used as a surrogate end point in research trials as a marker of atherosclerosis. However, new software programs have made CIMT a clinically practical examination for risk evaluation. CIMT correlates with cardiac risk factors and is an independent predictor of future myocardial infarction and stroke risk. Tests for subclinical atherosclerosis, such as CIMT, will help clinicians to more effectively identify the vulnerable patient who would benefit from aggressive prevention intervention.",
author = "Hurst, {R. Todd} and Ng, {Daniel W C} and Chris Kendall and Bijoy Khandheria",
year = "2007",
month = "7",
doi = "10.1016/j.echo.2007.02.028",
language = "English (US)",
volume = "20",
pages = "907--914",
journal = "Journal of the American Society of Echocardiography",
issn = "0894-7317",
publisher = "Mosby Inc.",
number = "7",

}

TY - JOUR

T1 - Clinical Use of Carotid Intima-Media Thickness

T2 - Review of the Literature

AU - Hurst, R. Todd

AU - Ng, Daniel W C

AU - Kendall, Chris

AU - Khandheria, Bijoy

PY - 2007/7

Y1 - 2007/7

N2 - Carotid intima-media thickness (CIMT) is a simple and inexpensive tool to assess the cumulative effect of atherosclerotic risk factors and is an independent predictor of future cardiovascular risk. CIMT is commonly used as a surrogate end point in research trials as a marker of atherosclerosis. However, new software programs have made CIMT a clinically practical examination for risk evaluation. CIMT correlates with cardiac risk factors and is an independent predictor of future myocardial infarction and stroke risk. Tests for subclinical atherosclerosis, such as CIMT, will help clinicians to more effectively identify the vulnerable patient who would benefit from aggressive prevention intervention.

AB - Carotid intima-media thickness (CIMT) is a simple and inexpensive tool to assess the cumulative effect of atherosclerotic risk factors and is an independent predictor of future cardiovascular risk. CIMT is commonly used as a surrogate end point in research trials as a marker of atherosclerosis. However, new software programs have made CIMT a clinically practical examination for risk evaluation. CIMT correlates with cardiac risk factors and is an independent predictor of future myocardial infarction and stroke risk. Tests for subclinical atherosclerosis, such as CIMT, will help clinicians to more effectively identify the vulnerable patient who would benefit from aggressive prevention intervention.

UR - http://www.scopus.com/inward/record.url?scp=34347355523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347355523&partnerID=8YFLogxK

U2 - 10.1016/j.echo.2007.02.028

DO - 10.1016/j.echo.2007.02.028

M3 - Article

VL - 20

SP - 907

EP - 914

JO - Journal of the American Society of Echocardiography

JF - Journal of the American Society of Echocardiography

SN - 0894-7317

IS - 7

ER -